g(m1)-ganglioside and Spinal-Cord-Diseases

g(m1)-ganglioside has been researched along with Spinal-Cord-Diseases* in 2 studies

Other Studies

2 other study(ies) available for g(m1)-ganglioside and Spinal-Cord-Diseases

ArticleYear
[A case of myeloradiculoneuropathy associated with persistent high titers of anti-GM1 and anti-GD1b antibodies].
    Rinsho shinkeigaku = Clinical neurology, 1997, Volume: 37, Issue:1

    A 60-year-old woman was admitted to our hospital with bilateral weakness of the lower limbs. She had been suffering from spastic paraparesis of unknown origin for 12 years since she was 48. Myelopathy with the Th6 level appeared when she was 52 and underwent gradual deterioration. On admission, she showed spastic paraparesis and myelopathy with the Th6 level. A thoracic spinal MRI examination revealed a wholly thin spinal cord. EMG demonstrated that the conduction velocity of the peroneal nerve was 37.8m/sec, and F waves were not evoked on stimulation of the peroneal nerve. Although the anti-GM1 and anti-GD1b antibody titers in the serum were increased on admission, their values decreased transiently after whole plasmapheresis. There was accompanying impairment of the radiculoneuropathy and myelopathy. It is important to measure the titers of anti-ganglioside antibodies in patients with myeloradiculoneuropathy of unknown origin, and whole plasmapheresis is considered to represent a useful treatment for this type of illness.

    Topics: Autoantibodies; Female; G(M1) Ganglioside; Gangliosides; Humans; Middle Aged; Peripheral Nervous System Diseases; Plasmapheresis; Spinal Cord Diseases; Spinal Nerve Roots

1997
Cholinergic deficits in aged rat spinal cord: restoration by GM1 ganglioside.
    Brain research, 1997, Jul-04, Volume: 761, Issue:2

    Cholinergic neurons of spinal cord are central for the processing of motor, autonomic, and sensory modalities. Aging is associated with a variety of motor and autonomic symptoms that might be attributed, in part, to impaired spinal cord function. We found that cholinergic neurochemistry is diminished in the spinal cord of 22-24-month-old rats compared with 3-month-old rats. Choline acetyltransferase, high-affinity choline transport and hemicholinium-3 binding to the choline carrier were reduced in the aged spinal cord. The activity of the choline transporter and the hemicholinium-3 binding were decreased in all spinal segments, cervical, thoracic, lumbar and sacral. Hemicholinium-3 binding was reduced in ventral and dorsal horns along all spinal segments. The activity of choline acetyltransferase was decreased only in cervical and lumbar cord. Treatment of aged animals with GM1 induced the recovery of the presynaptic cholinergic markers in the aged spinal cord.

    Topics: Acetylcholine; Aging; Animals; Carrier Proteins; Choline O-Acetyltransferase; Cholinergic Agents; Cholinergic Fibers; G(M1) Ganglioside; Hemicholinium 3; Male; Membrane Transport Proteins; Neurons; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Cord Diseases

1997